What We're Reading: Page 170
Industry reads hand-picked by our editors
Jan 26, 2021
-
STAT
'But I never smoked': A growing share of lung cancer is turning up in never-smokers
-
Science
Proud of vaccine success, Warp Speed's ex–science head talks politics, presidents, and future pandemics
-
Reuters
Novartis's regulatory delays add to pandemic sales hit
-
Kaiser Health News
Why Even Presidential Pressure Might Not Get More Vaccine to Market Faster
Jan 25, 2021
-
C&EN
COVID-19: Science's greatest test
-
STAT
Colchicine, a gout drug, shows preliminary promise for Covid-19
-
Kaiser Health News
They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to Pharma
-
The Wall Street Journal
Biden Team Promises New Look in Trade Policy
Jan 22, 2021
-
The Washington Post
Vaccine shortages intensify while some doses sit on shelves, an obstacle to national strategy promised by Biden
-
MedPage Today
New Safety Concern for Migraine Drug?
-
Bloomberg
J&J Vaccine Trial Has Enough Data to Analyze Soon, Fauci Says
-
Future Human
‘Deleted’ DNA Data Just Reappeared on a Popular Database
Jan 21, 2021
-
Reuters
California resumes Moderna COVID-19 vaccine usage after pause
-
STAT
CEO of Mark Cuban's generics company talks drug pricing, manufacturing
-
Associated Press
Fire hits building at Indian producer of COVID-19 vaccines
-
Endpoints News
BIO looks to restructure, laying off staff amid challenge to the trade org’s normal face-to-face style
Jan 20, 2021
-
The Wall Street Journal
Janet Woodcock to Lead FDA on Interim Basis
-
The Washington Post
Elderly begin to drop out of Novavax vaccine trial to get Pfizer and Moderna shots
-
Evaluate Vantage
The pandemic releases its grip on clinical trials
-
Vanity Fair
How Trump's COVID Chaos Drowned the FDA in Junk Science
Jan 19, 2021
Jan 15, 2021
-
The Washington Post
Vaccine reserve was already exhausted when Trump administration vowed to release it, dashing hopes of expanded access
-
FiercePharma
Bristol Myers hematology chief Ahmed's out the door amid CAR-T missteps
-
Bloomberg
Pfizer to Cut Covid Vaccine Deliveries as It Renovates Factory
-
Financial Times
New Bayer drugs will not bridge revenue gap, says pharma head
Previous
